Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urticaria pigmentosa.

Knut Brockow1

  • 1Department of Dermatology and Allergy Biederstein, Technical University Munich, Biedersteiner Strasse, 29 80802 Munich, Germany. knut.brockow@lrz.tum.de

Immunology and Allergy Clinics of North America
|May 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.

Journal of hematology & oncology·2026
Same author

Resolution of childhood wheat allergy through evolution into WALDA? A case report.

Allergologie select·2026
Same author

Demonstration of Gliadin Penetration into the Epidermis by Tape Stripping as Prerequisite for Percutaneous Sensitisation in Wheat Allergy.

International journal of molecular sciences·2026
Same author

Definition of Competencies for Allergology Specialty/Subspecialty Training in Mast Cell Disorders in Europe: An EAACI Position Paper.

Allergy·2026
Same author

Hypersensitivity to Excipients in Drugs: An EAACI Position Paper.

Allergy·2026
Same author

Casein as rare elicitor of food allergy dependent on augmentation factors - A case report.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Anaphylaxis: State-of-the-Art.

Immunology and allergy clinics of North America·2026
Same journal

Upending Impending Doom.

Immunology and allergy clinics of North America·2026
Same journal

Mast Cell Activation Syndrome and Mimickers.

Immunology and allergy clinics of North America·2026
Same journal

Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Emerging Therapies for Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Novel Epinephrine Delivery Devices.

Immunology and allergy clinics of North America·2026
See all related articles

Urticaria pigmentosa (UP) is a skin condition caused by excess mast cells. Adult-onset UP often stems from genetic mutations in KIT, driving new diagnostic and therapeutic strategies.

Area of Science:

  • Dermatology
  • Hematology
  • Oncology

Background:

  • Urticaria pigmentosa (UP) is the most prevalent form of cutaneous mastocytosis.
  • It involves the accumulation of excessive mast cells in the skin.
  • The disease exhibits significant clinical diversity.

Purpose of the Study:

  • To explore the genetic basis of adult-onset Urticaria Pigmentosa.
  • To identify new diagnostic markers for mastocytosis.
  • To investigate novel therapeutic targets for neoplastic mast cells.

Main Methods:

  • Analysis of genetic mutations in hematopoietic progenitor cells.
  • Observational studies on disease presentation and progression.
  • Exploration of KIT signaling pathways.

Related Experiment Videos

Main Results:

  • Clonal expansion of early hematopoietic progenitor cells with activating KIT mutations is implicated in adult-onset UP.
  • Understanding disease pathogenesis is crucial for developing new markers and therapies.
  • Targeting neoplastic mast cells shows promise.

Conclusions:

  • Activating KIT mutations are a key factor in adult-onset Urticaria Pigmentosa.
  • Further research into mastocytosis causes and KIT signaling pathways can yield effective treatments.
  • New diagnostic and therapeutic strategies are emerging for cutaneous mastocytosis.